VRTX - VERTEX PHARMACEUTICALS INC / MA
IEX Last Trade
411.11
-0.475 -0.116%
Share volume: 83,733
Last Updated: Wed 08 Jan 2025 08:30:16 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.55%
PREVIOUS CLOSE
CHG
CHG%
$411.58
-0.47
-0.12%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2023-05-02 | 2023-08-02 | 2023-11-07 | 2024-02-15 | 2024-05-07 | 2024-08-02 | 2024-11-05 | |
| Cash flow financing | -294.700 M | 17.300 M | -165.000 M | -119.800 M | -357.500 M | -358.600 M | -387.500 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | -89.100 M | |
| Cash flow | 899.900 M | 1.134 B | 1.268 B | 234.600 M | 1.307 B | -3.754 B | 634.300 M | |
| Net income | 699.800 M | 915.700 M | 1.035 B | 968.800 M | 1.100 B | -3.594 B | 1.045 B | |
| Depreciation | 38.800 M | 41.400 M | 42.100 M | 59.000 M | 53.500 M | 54.000 M | 53.200 M | |
| Changes in inventories | 535.100 M | 603.500 M | 688.700 M | 738.800 M | 813.100 M | 914.600 M | 0.000 | |
| Changes in receivables | 1.548 B | 1.556 B | 1.539 B | 1.563 B | 1.793 B | 1.656 B | 0.000 | |
| Investing Cashflow | -1.834 B | -303.900 M | -117.700 M | -886.500 M | -2.136 B | -463.700 M | -348.000 M | |
| Net Borrowings | -10.465 B | -11.309 B | -12.078 B | -11.415 B | -10.321 B | -6.024 B | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | -8.100 M | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -42.100 M | -59.600 M | -40.600 M | -116.100 M | -68.400 M | -69.000 M | 67.700 M | |
| Cash Change | 10.414 B | 11.236 B | 11.928 B | 11.218 B | 10.171 B | 5.796 B | 657.100 M |